A Study to Evaluate the Safety and Efficacy of AVTX-002 for the Treatment of Poorly Controlled Non-Eosinophilic Asthma.
Clinical trial NCT05288504 · COMPLETED
Trial details
- NCT number
- NCT05288504
- Sponsor
- Avalo Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-24
- Primary completion
- 2023-05-11
- Enrollment
- 91
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.